Medicare Enrolled
Dr. Hrach Khudatyan, M.D.
Family Medicine · Glendale, CA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Khudatyan from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Khudatyan?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Khudatyan
Dr. Hrach Khudatyan is a family medicine specialist in Glendale, CA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Khudatyan performed 17,364 Medicare services across 4,661 unique beneficiaries.
Between the years covered by Open Payments, Dr. Khudatyan received a total of $17,740 from 65 pharmaceutical and/or device companies across 828 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in family medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Khudatyan is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 1% volume in CA
$17,740 industry payments
Medicare Practice Summary
Medicare Utilization ↗17,364
Medicare services
Top 1% in CA for family medicine
4,661
Unique beneficiaries
$46
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~868 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
6,463 | $76 | $160 |
| Destruction of precancerous skin growths, 2-14 This procedure involves the removal or destruction of two to fourteen precancerous skin lesions. It is performed to eliminate abnormal skin cells that have the potential to develop into cancer. |
2,302 | $6 | $13 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
1,348 | $12 | $55 |
| Vitamin B-12 injection An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg. |
1,055 | $1 | $20 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
912 | $8 | $10 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
435 | $49 | $96 |
| Blood glucose test using hand-held instrument A test that measures the level of sugar in the blood using a portable device. The result helps monitor blood glucose levels. |
406 | $3 | $15 |
| Smoking cessation counseling, 4-10 minutes A brief counseling session focused on helping patients quit smoking and tobacco use. The provider spends 4 to 10 minutes discussing strategies and support for cessation. |
390 | $16 | $31 |
| Obesity behavioral counseling, 15 minutes A 15-minute face-to-face session focused on behavioral counseling to help manage obesity. |
350 | $27 | $57 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
327 | $105 | $235 |
| Annual depression screening | 321 | $21 | $41 |
| Annual alcohol misuse screening, 5 to 15 minutes | 319 | $21 | $41 |
| Advance care planning consultation, first 30 min A session focused on discussing and documenting future healthcare preferences and goals. This service covers the initial 30 minutes of the planning discussion. |
315 | $69 | $200 |
| Annual intensive behavioral therapy for cardiovascular disease, 15 minutes A yearly, in-person session focused on intensive behavioral therapy to help manage cardiovascular disease. The session lasts for 15 minutes and is conducted with the patient individually. |
312 | $28 | $50 |
| Annual wellness visit, follow-up A follow-up annual wellness visit that includes a personalized prevention plan of service. |
302 | $140 | $250 |
| Destruction of precancerous skin growth, 1 Removal of a single precancerous skin growth. This procedure destroys abnormal skin cells to prevent them from developing into cancer. |
263 | $59 | $150 |
| Neurobehavioral status exam, first hour A clinical assessment of neurobehavioral status lasting one hour. This evaluation examines mental and behavioral functions. |
234 | $78 | $200 |
| Ear wax removal A procedure to remove impacted ear wax from the ear canal. |
217 | $38 | $118 |
| Steroid injection (triamcinolone) A 10 mg injection of triamcinolone acetonide, a corticosteroid medication. This code specifies the drug and dosage administered. |
183 | $1 | $10 |
| Home health plan of care re-certification A physician reviews the patient's status and contacts the home health agency to re-certify the plan of care without the patient being present. |
108 | $37 | $80 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
105 | $12 | $37 |
| Home health plan of care certification Certification by a physician or allowed practitioner for Medicare-covered home health services under a home health plan of care. This includes contacting the home health agency and reviewing reports of patient status required by physicians. |
104 | $46 | $125 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
94 | $66 | $154 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
80 | $100 | $222 |
| Transitional care management, high complexity Coordination of care for a patient transitioning from a short-term hospital stay or other facility to home or another care setting. This service addresses a high-complexity medical problem. |
70 | $241 | $450 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
61 | $146 | $313 |
| Joint injection, major joint Removal of fluid from a large joint and/or injection of medication into the joint space. |
58 | $41 | $134 |
| Breathing device use evaluation An assessment of how a patient uses a breathing device. The provider reviews the patient's technique and device handling. |
47 | $15 | $41 |
| Destruction of 15 or more precancerous skin growths This procedure involves the removal or destruction of fifteen or more precancerous skin lesions. It is performed to treat abnormal skin cells that have the potential to develop into cancer. |
45 | $146 | $339 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
32 | $141 | $433 |
| Hospital discharge management, 30+ min This service covers the care provided by a physician or qualified healthcare professional on the day a patient is discharged from the hospital. It requires more than 30 minutes of total time spent on the day of discharge. |
29 | $96 | $230 |
| Suprascapular nerve injection An injection of anesthetic and/or steroid medication into the suprascapular nerve in the shoulder area. |
24 | $76 | $333 |
| Continuous glucose monitoring, tissue fluid This procedure involves continuous monitoring of blood sugar levels in tissue fluid using a sensor placed under the skin. |
17 | $57 | $150 |
| Flu vaccine, quadrivalent A flu shot containing four strains of the influenza virus to help prevent seasonal influenza infection. |
12 | $0 | $0 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
12 | $83 | $352 |
| Flu vaccine administration This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient. |
12 | $33 | $50 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$17,740
Total received (2018-2024)
Avg $2,534/year across 7 years
Top 2% in CA for family medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
65
Companies
828
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$17,740 (100.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$3,288
2023
$2,673
2022
$2,651
2021
$2,977
2020
$1,224
2019
$2,379
2018
$2,548
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$380
Amgen Inc.
$302
Lundbeck LLC
$242
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$233
AstraZeneca Pharmaceuticals LP
$221
Otsuka America Pharmaceutical, Inc.
$199
AIMMUNE THERAPEUTICS, INC.
$168
Ardelyx, Inc.
$154
Sumitomo Pharma America, Inc.
$122
Boehringer Ingelheim Pharmaceuticals, Inc.
$116
Phathom Pharmaceuticals, Inc.
$112
Merck Sharp & Dohme LLC
$112
Esperion Therapeutics, Inc.
$107
Bayer Healthcare Pharmaceuticals Inc.
$86
GlaxoSmithKline, LLC.
$82
Novo Nordisk Inc
$81
Lilly USA, LLC
$72
IDORSIA PHARMACEUTICALS US INC
$67
E.R. Squibb & Sons, L.L.C.
$59
IRONWOOD PHARMACEUTICALS, INC
$51
PFIZER INC.
$51
Xeris Pharmaceuticals, Inc.
$42
ANI Pharmaceuticals, Inc.
$41
Takeda Pharmaceuticals U.S.A., Inc.
$32
Novartis Pharmaceuticals Corporation
$32
SHIELD THERAPEUTICS INC
$31
Exact Sciences Corporation
$27
VIVUS LLC
$25
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
$23
Kowa Pharmaceuticals America, Inc.
$19
Top 3 companies account for 28.1% of 2024 payments
All-time payments by company (2018-2024) ›
AstraZeneca Pharmaceuticals LP
$1,590
Amgen Inc.
$1,419
ABBVIE INC.
$1,232
Horizon Therapeutics plc
$1,003
Boehringer Ingelheim Pharmaceuticals, Inc.
$817
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$792
Takeda Pharmaceuticals U.S.A., Inc.
$692
GlaxoSmithKline, LLC.
$667
PFIZER INC.
$658
Lundbeck LLC
$580
Novo Nordisk Inc
$572
Esperion Therapeutics, Inc.
$564
Lilly USA, LLC
$537
Amarin Pharma Inc.
$524
Ironwood Pharmaceuticals, Inc
$432
AbbVie Inc.
$384
Merck Sharp & Dohme Corporation
$335
Astellas Pharma US Inc
$334
SANOFI-AVENTIS U.S. LLC
$253
Bayer Healthcare Pharmaceuticals Inc.
$233
Regeneron Healthcare Solutions, Inc.
$230
Otsuka America Pharmaceutical, Inc.
$223
AbbVie, Inc.
$219
Merck Sharp & Dohme LLC
$194
E.R. Squibb & Sons, L.L.C.
$182
Allergan Inc.
$178
Nestle HealthCare Nutrition Inc.
$175
Kowa Pharmaceuticals America, Inc.
$173
AIMMUNE THERAPEUTICS, INC.
$168
Ardelyx, Inc.
$154
Avanir Pharmaceuticals, Inc.
$153
Novartis Pharmaceuticals Corporation
$152
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$125
Sumitomo Pharma America, Inc.
$122
Eisai Inc.
$115
Phathom Pharmaceuticals, Inc.
$112
Bausch Health US, LLC
$112
IDORSIA PHARMACEUTICALS US INC
$112
Corium, LLC
$103
Vanda Pharmaceuticals Inc.
$90
ARBOR PHARMACEUTICALS, INC.
$88
IRONWOOD PHARMACEUTICALS, INC
$85
Janssen Pharmaceuticals, Inc
$79
Bayer HealthCare Pharmaceuticals Inc.
$76
Actelion Pharmaceuticals US, Inc.
$72
ANI Pharmaceuticals, Inc.
$64
Noden Pharma USA Inc
$49
Azurity Pharmaceuticals, Inc.
$45
Allergan, Inc.
$44
Arbor Pharmaceuticals, Inc.
$43
Xeris Pharmaceuticals, Inc.
$42
SUN PHARMACEUTICAL INDUSTRIES INC.
$31
SHIELD THERAPEUTICS INC
$31
Circassia Pharmaceuticals Inc
$30
Radius Health, Inc.
$30
Biohaven Pharmaceutical Holding Company Ltd.
$28
Exact Sciences Corporation
$27
VIVUS LLC
$25
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
$23
Biohaven Pharmaceuticals, Inc.
$23
SANOFI PASTEUR INC.
$23
Biogen, Inc.
$21
Vertiflex, Inc.
$18
IMPEL PHARMACEUTICALS INC.
$18
Medicure Pharma Inc.
$15
Top 3 companies account for 23.9% of all-time payments
Associated products mentioned in payments ›
ACCRUFER · ADLARITY · ADVAIR · ANORO · ANORO ELLIPTA · Adlarity · Aimovig · BELSOMRA · BREZTRI · BREZTRI AEROSPHERE · BRINTELLIX · BYDUREON · CAPLYTA · COBENFY · COLOGUARD DNA CAPTURE REAGENTS · CREON · Cologuard Collection Kit · Creon · Dayvigo · ELIQUIS · ENTRESTO · EUCRISA · Edarbi · Edarbyclor · FARXIGA · FLUZONE HIGH-DOSE · GEMTESA · GLYXAMBI · GVOKE HYPOPEN · Hetlioz · Horizant · IBSRELA · INVOKANA · JANUVIA · JARDIANCE · KAPSPARGO · KRYSTEXXA · Kerendia · LEQVIO · LINZESS · LOKELMA · LYRICA · LifeVest · Linzess · Livalo · MIGRANAL · MOTEGRITY · MOUNJARO · MYRBETRIQ · Motegrity · Myrbetriq · NEXLETOL · NEXLIZET · NUEDEXTA · NURTEC ODT · Otezla · Ozempic · PANCREAZE · PENNSAID · PRALUENT · PRALUENT ALIROCUMAB INJECTION · PREVNAR - 13 · PURIFIED CORTROPHIN GEL · Prolia · QULIPTA · QUVIVIQ · RAYOS · REXULTI · RYBELSUS · Repatha · Rybelsus · SOLIQUA · SPIRIVA RESPIMAT · STIOLTO RESPIMAT · SYMBICORT · Superion ISS · TEKTURNA · TRADJENTA · TRELEGY ELLIPTA · TRINTELLIX · TRULANCE · TRULICITY · TUDORZA PRESSAIR · Trintellix · Trudhesa · Tymlos · UBRELVY · UPTRAVI · VERQUVO · VIBERZI · VIIBRYD · VIMOVO · VOQUEZNA · VRAYLAR · Vascepa · Veozah · Victoza · XARELTO · XIFAXAN · XIIDRA · ZENPEP · ZORYVE · ZYPITAMAG
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 2% for family medicine in CA.
Geographic Context
Family medicine physicians within 10 mi
3,038
Per 100K population
30.8
County median income
$87,760
Nearest hospital
GLENDALE ADVENTIST MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Khudatyan is a clinical cardiology specialist, with above-average Medicare volume (top 1% in CA), with low-engagement industry engagement in the top 2% of CA peers, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Khudatyan experienced with office visit, established patient (20-29 min)?
Based on Medicare claims data, Dr. Khudatyan performed 6,463 office visit, established patient (20-29 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Khudatyan receive payments from pharmaceutical companies?
Yes. Dr. Khudatyan received a total of $17,740 from 65 companies across 828 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Khudatyan's costs compare to other family medicine physicians in Glendale?
Dr. Khudatyan's average Medicare payment per service is $46. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Khudatyan) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Family Medicine
Common procedures, typical costs, and what industry payments mean in family medicine.
Same specialty & city
Family Medicine Physicians in Glendale
Browse family medicine physicians in Glendale ranked by procedure volume and transparency data.
Highest volume
Top Family Medicine Physicians in CA
Family medicine physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Family Medicine Physicians in CA
Which CA family medicine physicians receive the most from drug and device companies.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
By company
ABBVIE INC. Payments to Doctors
See all physicians who received payments from ABBVIE INC.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology